HEALTH TECHNOLOGY

Vitestro unveils autonomous blood drawing device, combining artificial intelligence, ultrasound imaging and robotics

Vitestro | May 31, 2022

Vitestro unveils

Vitestro, a Dutch medical robotics company, unveiled the world's most advanced autonomous blood drawing device at the annual meeting of the Netherlands Society for Clinical Chemistry and Laboratory Medicine in Rotterdam. Vitestro's device combines AI-based, ultrasound-guided 3D reconstruction with robotic needle insertion, ensuring accurate and secure blood collection. The venipuncture technology is adaptable to patients of 16 years of age onwards, comorbidities, and puncture difficulty. From 2023, Vitestro will initiate pivotal clinical studies for regulatory approval in Europe. EU-market introduction is anticipated in 2024.

Healthcare shortages spark revolutionary developments
Within healthcare, the clinical laboratory is the driving force. Accuracy and timeliness of laboratory tests are critically important, as they shape approximately 70% of all medical decisions made by physicians. It is unsurprising that blood collection is the most common invasive medical procedure, performed billions of times per year globally. Blood collection holds a pivotal role in clinical diagnostics yet is also burdened by the scarcity of skilled workers. By automating this labor-intensive procedure, we can transform the quality of care and create a sustainable healthcare system. 

Proprietary laboratory automation technology standardizes handling of the blood sample while the blood is collected. The device allows almost complete automation of the pre-analytical phase. This has the potential to reduce high blood test error rates, mainly caused by manual variability. In clinical studies, Vitestro already performed 1,500 automated blood draws in more than 1,000 patients with its prototype.

Toon Overbeeke, Vitestro's Co-Founder and Chief Executive Officer said:

"The mounting shortage of healthcare personnel is imminent. The pandemic has further led to loss of workforce, causing a bleak outlook for hospital output around the globe, and leading to reduced access and continuity of care. That's why revolutionary automation like our blood drawing device is inevitable to solve the industry's biggest problem."

Outpatient phlebotomy care is redefined
At first, Vitestro will implement the device in outpatient phlebotomy departments. Patients will have the option to choose between Vitestro's venipunture device or standard method. The device is intuitive to use, empowering patients to be self-reliant in the full blood collection procedure. In previous clinical trials, patients of all ages showed a high degree of openness, enthusiasm and willingness to adopt the innovation.

A trained healthcare professional is able to supervise several devices, managing multiple patients simultaneously. The increased efficiency enables hospitals and clinical laboratories to address workforce shortage or even free up staff and deploy them where they are really needed.

"We have spent nearly five years on the development of this breakthrough medical device. All relevant disciplines are represented in our dedicated, specialized team of 35 people. To prepare for production and commercialization, the team will double in size in the next two years. We have clear momentum in the market and will be the first to bring autonomous technology to European hospitals. With our technology we can help to build a more robust and resilient healthcare system."

Toon Overbeeke, Vitestro's Co-Founder and Chief Executive Officer

Anja Leyte, Director OVLG Laboratories, participating in clinical studies commented: 
"By introducing automated blood drawing, high quality as well as capacity is guaranteed in our laboratories. Vitestro's technology helps solving staffing shortages at our blood drawing department and improving sample standardization. Patients are also very enthusiastic."

About Vitestro
In 2017 Vitestro's founders rose to the challenge to create a better blood drawing experience. Today Vitestro is well underway to achieve its goal with a committed team of 35 highly skilled people with a track record in medical robotics, imaging software, AI, QA/RA and business development. Vitestro is based in Utrecht, the Netherlands. Vitestro is well funded by private investors and government subsidies.

Spotlight

As demands for quality and accessible public healthcare services in Sinjar are on the rise, we are expanding our support for Sinjar’s healthcare sector.

Spotlight

As demands for quality and accessible public healthcare services in Sinjar are on the rise, we are expanding our support for Sinjar’s healthcare sector.

Related News

HEALTH TECHNOLOGY, FUTURE OF HEALTHCARE

eSight Introduces New Assistive Device for Legally Blind People

eSight | January 04, 2023

eSight, a leading vision-enhancement platform, announced the launch of eSight Go, its most recent innovation in assistive technology. With its enhanced visual clarity, lightweight design, and expansive field of view, the wearable gadget establishes a new benchmark for enhanced vision technology, allowing people with central vision loss to gain independence in their daily lives. The company said that it has greatly improved the capacity and design of its digital eyewear. It is not only to help people who are blind see better but also to make their lives smoother and more manageable. Through a flexible, wearable design that does not restrict the wearer's peripheral vision, eSight devices improve vision for thousands of people with over 20 eye conditions. In addition, the mobility-preserving structure of eSight Go allows for use anywhere, at any time. eSight Go uses the best-matched camera and lens to project a superior image onto two high-resolution screens for binocular vision. Its users can alter the internal OLED's color and contrast. A broader field of view (45 degrees) amplifies vision for unrivaled mobility. Additionally, its new features include better navigation and image stabilization software, a 12-megapixel camera, 4K capabilities, and full HD OLED panels that deliver the sharpest picture with 170 grams comfortably distributed around the neck. eSight Go will debut at CES 2023 and launch in Q4 2023. The device will be showcased at the Gentex booth (#6341) from January 5-8, 2023. About eSight eSight is an innovative vision platform that promises to help people who are blind see new opportunities. It helps patients with macular degeneration, diabetic retinopathy, and 50 other vision-loss conditions. The first eSight Eyewear prototype was released in 2013. Time Magazine named eSight 3 one of 'The 25 Best Inventions of 2017' while Buzzfeed named it one of the '6 Inventions Changing British Lives in 2017'.

Read More

FUTURE OF HEALTHCARE, HEALTHCARE ANALYTICS

Stericycle Completes Divestiture of Communication Solutions Business to Carenet Health

Stericycle, Inc. | December 05, 2022

Stericycle, Inc. a leading provider of regulated medical waste management and secure information destruction solutions, announced that it has completed the divestiture of its Communication Solutions business to Carenet Health, one of the healthcare industry’s leading consumer engagement and telehealth partners, for approximately $45 million in cash, subject to customary adjustments. Stericycle intends to use the net proceeds from the divestiture to pay down outstanding debt. Stericycle Communication Solutions provides online scheduling, automated messaging and strategic inbound and outbound call center services to drive patient access, action and adherence. For the nine months ended September 30, 2022, the Communication Solutions business had revenues of approximately $45 million, reported in the North America segment, as part of Regulated Waste and Compliance Services revenues. In connection with the closing, Stericycle and Carenet Health entered into a purchase and transition services agreements. The divested business includes approximately 500 team members in North America. “The sale of Stericycle Communication Solutions demonstrates our continued commitment to deliver on our portfolio optimization key business priority, marking our eleventh divestiture since 2019. By further streamlining our company, we are taking another step in our journey to focus on our core businesses and improve sustainable operational efficiencies. I would like to thank our team members transitioning to Carenet Health and wish them much success as they work to deliver better experiences and outcomes across the patient journey." Cindy J. Miller, chief executive officer of Stericycle About Carenet Health Carenet Health is one of the healthcare industry’s leading consumer engagement and telehealth partners—providing consumer engagement, clinical support, virtual care and advocacy solutions on behalf of 250+ of the nation’s premier health plans, providers, health systems and Fortune 500 companies. One in four Americans have access to Carenet’s services. Carenet is headquartered in San Antonio, Texas, with additional office locations in New Mexico, Maine and the Philippines. About Stericycle Stericycle, Inc., is a U.S. based business-to-business services company and leading provider of compliance-based solutions that protects people and brands, promotes health and well-being, and safeguards the environment. Stericycle serves customers in the U.S. and 16 countries with solutions for regulated waste and compliance services and secure information destruction.

Read More

HEALTH TECHNOLOGY, MEDICAL DEVICES

Elara Caring and ServiceNow Drive Tech Innovations in Home Health

Elara Caring | December 09, 2022

Elara Caring, the full-scale, multi-state home healthcare provider of clinical and personalized services across the patient/client continuum, is working with ServiceNow to empower its caregiver workforce to deliver vital services to patients and clients wherever they call home. ServiceNow will equip Elara’s caregivers with market-leading, cloud-based, mobile-enabled solutions that simultaneously improve patient/client outcomes and the caregiver experience, while helping cut costs, retain a mobile workforce, and optimize operations. Specific technologies to be deployed include automated appointment scheduling; on-the-go schedule management and shift offerings; GPS-based travel route guidance; pre-visit management; digital documentation; and a 360-degree portal for patients/clients, their authorized family members and Elara. The move reflects Elara’s commitment to mission-driven innovation, stemming from its state-of-the-art care platform, ElaraConnect, which leverages advanced technology to monitor, anticipate and meet patient/client needs. The platform uses digital monitoring, data-enabled insights and change-in-condition alerts that allow for proactive and timely interventions. In addition, it allows for a seamless transition to more cost-effective and progressive care paths for chronically ill patients. “Our high-tech, high-touch approach to keeping patients and clients healthy and out of the hospital not only best serves the needs of our patient/client population and their families, but aligns the historically conflicting interests of patients and payers. Working with ServiceNow only further enhances our technology-driven focus on patient vitality, improving outcomes for all stakeholders.” Scott Powers, CEO of Elara Caring "We’re proud to help Elara Caring make healthcare more human by connecting teams and streamlining processes as they redefine the future of patient care,” said Mike Luessi, head of healthcare and life sciences at ServiceNow. “Delivering seamless patient experiences, while also achieving operational excellence at targeted expense levels, is a goal shared by many healthcare providers today. Digital transformation is a key enabler to accomplishing this formidable challenge, and our initial work with Elara Caring represents just the beginning of the impact that can be achieved.” Elara has initiated a rollout of ServiceNow offerings for caregivers delivering Personal Care Services to clients within New York State. Elara Caring is one of the nation’s leading providers of home-based care, offering Skilled Home Health, Hospice, Personal Care Services, Behavioral Health and Palliative Care. With a footprint in 16 states in the Northeast, Midwest and Southwest, it serves more than 60,000 patients and their families across 200 locations. The Elara Caring mission is to deliver exceptional, personalized health care services wherever patients call home. The company accomplishes this by hiring compassionate people who believe in taking care of its patients, clients, care providers and each other.

Read More